>
Switch to:

Keros Therapeutics EV-to-EBIT

: -22.70 (As of Today)
View and export this data going back to 2020. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Keros Therapeutics's Enterprise Value is $1,001.66 Mil. Keros Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $-44.13 Mil. Therefore, Keros Therapeutics's EV-to-EBIT for today is -22.70.

NAS:KROS' s EV-to-EBIT Range Over the Past 10 Years
Min: -41.45   Med: -28.02   Max: -12.01
Current: -22.53

-41.45
-12.01

During the past 3 years, the highest EV-to-EBIT of Keros Therapeutics was -12.01. The lowest was -41.45. And the median was -28.02.

NAS:KROS's EV-to-EBIT is ranked lower than
99.99% of the 265 Companies
in the Biotechnology industry.

( Industry Median: 31.85 vs. NAS:KROS: -22.53 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Keros Therapeutics's Enterprise Value for the quarter that ended in Dec. 2020 was $1,371.05 Mil. Keros Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was $-44.13 Mil. Keros Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -3.22%.


Keros Therapeutics EV-to-EBIT Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keros Therapeutics Annual Data
Dec18 Dec19 Dec20
EV-to-EBIT 0.00 0.00 -31.07

Keros Therapeutics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -22.10 -17.84 -31.07

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Keros Therapeutics EV-to-EBIT Distribution

* The bar in red indicates where Keros Therapeutics's EV-to-EBIT falls into.



Keros Therapeutics EV-to-EBIT Calculation

Keros Therapeutics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1001.662/-44.127
=-22.70

Keros Therapeutics's current Enterprise Value is $1,001.66 Mil.
Keros Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was -10.504 (Mar. 2020 ) + -10.914 (Jun. 2020 ) + -12.034 (Sep. 2020 ) + -10.675 (Dec. 2020 ) = $-44.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Keros Therapeutics  (NAS:KROS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Keros Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2020 ) =EBIT / Enterprise Value (Q: Dec. 2020 )
=-44.127/1371.050166
=-3.22 %

Keros Therapeutics's Enterprise Value for the quarter that ended in Dec. 2020 was $1,371.05 Mil.
Keros Therapeutics's EBIT for the trailing twelve months (TTM) ended in Dec. 2020 was -10.504 (Mar. 2020 ) + -10.914 (Jun. 2020 ) + -12.034 (Sep. 2020 ) + -10.675 (Dec. 2020 ) = $-44.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Keros Therapeutics EV-to-EBIT Related Terms


Keros Therapeutics EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)